Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Tumor Profiling Industry Expansion: How the Market Size Has Grown Over the Last 5 Years?
In the past few years, the size of the tumor profiling market has experienced swift growth. It is projected to expand from $10.16 billion in 2024 to $11.18 billion in 2025, representing a compound annual growth rate (CAGR) of 10.0%.
Factors contributing to the growth over the historic period include an upsurge in cancer cases, heightened demand for personalized medicine, increased healthcare spending, greater adoption of companion diagnostics, and amplified awareness pertaining to early cancer detection.
The market size of tumor profiling is predicted to witness a swift escalation in the forthcoming years, with an estimated value of $16.37 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The anticipated growth during the forecast period can be credited to the increasing grafting of liquid biopsy techniques, a surge in investments devoted to cancer research and development, the rise in the elderly population, escalating utilization of targeted therapies, and the growing number of collaborations in cancer research.
During the forecasted period, we can anticipate significant trends such as a gradual shift towards companion diagnostics, an increase in multi-gene testing, advancements in next-generation sequencing technology, the incorporation of artificial intelligence (AI) in cancer diagnosis, and progressive developments in tumor profiling technologies.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Growth Drivers Are Responsible for Accelerating Tumor Profiling Market Growth?
The tumor profiling market is expected to experience growth propelled by the increasing demand for personalized medicine. Personalized medicine denotes that treatment plans are customized to meet the individual needs and characteristics of each patient.
This surge is due to patients desiring more precision in their therapies for optimal results and minimal side effects, compared to conventional treatments. Tumor profiling is benefiting personalized medicine by identifying specific genetic anomalies and biomarkers in a patient’s tumor.
This way, treatment can be more targeted, thus minimizing side effects. For example, a report by the Personalized Medicine Coalition, a US organization committed to promoting personalized medicine, noted in February 2024 that personalized medicines constituted over one-third of all new drug approvals in 2023.
This was the fourth consecutive year of such a trend. Therefore, the escalating demand for personalized medicine is fueling the expansion of the tumor profiling market.
Performance of Leading Segments in the Tumor Profiling Global Market
The tumor profilingmarket covered in this report is segmented –
1) By Technique: Genomics; Proteomics; Epigenetics; Metabolomics
2) By Technology: Sequencing Techniques; Quantitative Polymerase Chain Reaction (qPCR); Immunohistochemistry; In Situ Hybridization (ISH); Microarray
3) By Application: Personalized Cancer Medicine; Oncological Diagnostics; Research
Subsegments:
1) By Genomics: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarrays; Sanger sequencing
2) By Proteomics: Mass Spectrometry (MS); Protein Microarrays; Immunohistochemistry (IHC); Western Blotting
3) By Epigenetics: DNA Methylation Analysis; Chromatin Immunoprecipitation Sequencing (ChIP-seq); Histone Modification Profiling; Non-Coding RNA Analysis
4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy; Gas Chromatography-Mass Spectrometry (GC-MS); Liquid Chromatography-Mass Spectrometry (LC-MS); Capillary Electrophoresis-Mass Spectrometry (CE-MS)
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What are the upcoming Trends Poised to Transform the Future of the Tumor Profiling Market?
Leading firms in the tumor profiling market, such as Panakeia Technologies LTD, are concentrating on creating innovative techniques, like artificial intelligence (AI)-driven diagnostic solutions, to boost precision and effectiveness in cancer care. Artificial intelligence involves the employment of cutting-edge computational techniques to process intricate genomic, proteomic, and clinical data.
This allows for quicker diagnoses, tailored treatment plans, and improved tracking of disease advancement. Case in point, Panakeia Technologies LTD, a UK firm that specializes in AI-supported software for cancer detection and therapy, introduced an AI-facilitated software solution known as PANProfiler Colon in January 2025.
The program was specially crafted to profile crucial molecular biomarkers such as microsatellite instability (MSI) and mismatch repair deficiency (dMMR) — from H and E-stained images of colon cancer tissue samples. This digital utility tool facilitates swift and precise molecular profiling of tumors, which is crucial in diagnosing colorectal cancer and Lynch syndrome cases and guiding personalized treatment selections.
What Are the Regional Hotspots for Tumor Profiling Market Growth?
North America was the largest region in the tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The regions covered in the tumor profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Which Companies Hold the Largest Market Share in the Tumor Profiling Industry?
Major companies operating in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt.
Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., Predictive Oncology Inc.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=24420
How Our Market Research Reports Help Maximize ROI Across Industries:
*Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
*Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
*Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
